Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2025-12-24 @ 11:35 PM
NCT ID:
NCT01869556
Eligibility Criteria:
Inclusion Criteria:
* patients who give written informed consent
* patients undergoing Cesarean section for failure to progress in labour, under regional anesthesia
* patients should be in the first stage of labour and have received oxytocin for at least 4 hours
Exclusion Criteria:
* patients who refuse to give written informed consent
* patients who require general anesthesia
* patients who claim allergy or hypersensitivity to oxytocin, ergot derivatives or prostaglandins
* patients with cardiac diseases and hypertension or preeclampsia ( diastolic blood pressure \> 90 mmHg, systolic blood pressure \> 140 mmHg )
* patients with asthma or any other respiratory disease
* patients with conditions at risk of PPH such as placenta previa, multiple gestation, preeclampsia, macrosomia, polyhydramnios, uterine fibroids, previous history of uterine atony and postpartum bleeding, bleeding diathesis and known infection.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
14 Years
Maximum Age:
55 Years
Study:
NCT01869556
Study Brief:
Protocol Section:
NCT01869556